文献速递呼吸衰竭与机械通气儿科与产科急症

COVID-19 疫情后儿科急诊呼吸道病毒检测趋势

Trends in Respiratory Viral Testing in Pediatric Emergency Departments Following the COVID-19 Pandemic.
PubMed 文献 · Ann Emerg Med · 2024-10-16
一句话结论COVID-19 疫情后儿科急诊呼吸道病毒检测及费用上升并持续,作者认为需明确检测指征以减少低价值检测。

该横断面研究利用儿科健康信息系统,纳入2016年10月至2024年3月34个儿科急诊出院的90天至18岁患儿共15,261,939次就诊。采用中断时间序列分析,比较疫情前、疫情早期和疫情后期的病毒检测频率与费用。疫情前至少1次病毒检测比例为6.3%,疫情早期升至24.3%,疫情后期为19.1%。检测费用斜率从每月$5,000升至疫情早期的每月$33,000。作者认为需进一步明确急诊病毒检测指征并减少低价值检测。

要点

  • 纳入15,261,939次儿科急诊就诊,至少1次呼吸道病毒检测比例疫情前6.3%、疫情早期24.3%、疫情后期19.1%。
  • 疫情早期检测比例出现4.98%的水平偏移(95%CI 4.90至5.07),斜率0.54%/月(95%CI 0.54至0.55)。
  • 疫情后期检测比例出现-17.80%的水平偏移(95%CI -17.90至-17.70),斜率0.42%/月(95%CI 0.41至0.42)。
  • 检测费用斜率从疫情前每月$5,000(95%CI $4,200至$5,700)升至疫情早期每月$33,000(95%CI $32,000至$34,000)。
  • 作者认为需进一步明确急诊病毒检测指征,并努力减少低价值检测。

适用人群与场景

  • 90天至18岁、从儿科急诊出院并纳入儿科健康信息系统的儿童。
  • 研究期间为2016年10月至2024年3月。

研究设计与关键结果

  • 研究类型:横断面研究,使用儿科健康信息系统数据,共纳入34个儿科急诊的15,261,939次就诊,研究期90个月。
  • 疫情前(2016年10月1日至2020年3月14日)7,311,177次就诊中460,826次至少进行1次呼吸道病毒检测(6.3%)。
  • 疫情早期(2020年3月15日至2023年12月31日)5,100,796次就诊中1,240,807次至少进行1次检测(24.3%)。
  • 疫情后期(2023年1月1日至2024年3月31日)2,849,966次就诊中545,696次至少进行1次检测(19.1%)。
  • 疫情前检测比例斜率0.17%/月(95%CI 0.17至0.18)。
  • 疫情早期检测比例水平偏移4.98%(95%CI 4.90至5.07),斜率0.54%/月(95%CI 0.54至0.55)。
  • 疫情后期检测比例水平偏移-17.80%(95%CI -17.90至-17.70),斜率0.42%/月(95%CI 0.41至0.42)。
  • 检测费用斜率从疫情前每月$5,000(95%CI $4,200至$5,700)升至疫情早期每月$33,000(95%CI $32,000至$34,000)。

证据类型、等级与局限

  • 证据类型:横断面研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,需进一步努力明确急诊病毒检测指征,并减少低价值检测。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: To evaluate for increases in the use and costs of respiratory viral testing in pediatric emergency departments (EDs) because of the COVID-19 pandemic.

METHODS: We performed a cross-sectional study using the pediatric health information system. Eligible subjects were children (90 days to 18 years) who were discharged from a pediatric ED and included in the pediatric health information system from October 2016 through March 2024. To evaluate for changes in the frequency and costs of respiratory viral testing, we performed an interrupted time series analysis across 3 study periods: prepandemic (October 1, 2016 to March 14, 2020), early pandemic (March 15, 2020 to December 31, 2023), and late pandemic (January 1, 2023 to March 31, 2024).

RESULTS: We included 15,261,939 encounters from 34 pediatric EDs over the 90-month study period. At least 1 viral respiratory test was performed for 460,826 of 7,311,177 prepandemic encounters (6.3%), 1,240,807 of 5,100,796 early pandemic encounters (24.3%), and 545,696 of 2,849,966 late pandemic encounters (19.1%). There was a positive prepandemic slope in viral testing (0.17% encounters/month; 95% CI 0.17 to 0.18). The early pandemic was associated with a shift change of 4.98% (95% CI 4.90 to 5.07) and a positive slope (0.54% encounters/month; 95% CI 0.54 to 0.55). The late pandemic period was associated with a negative shift (-17.80%; 95% CI -17.90 to -17.70) and a positive slope (0.42% encounters/month; 95% CI 0.41 to 0.42). The slope in testing costs increased from $5,000/month (95% CI $4,200 to $5,700) to $33,000/month (95% CI $32,000 to $34,000) during the early pandemic.

CONCLUSION: Respiratory testing and associated costs increased during the COVID-19 pandemic and were sustained despite decreasing incidence of disease. These findings highlight a need for further efforts to clarify indications for viral testing in the ED and efforts to reduce low-value testing.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Ramgopal S, Badaki-Makun O, Eltorki M, et al. Trends in Respiratory Viral Testing in Pediatric Emergency Departments Following the COVID-19 Pandemic. Ann Emerg Med. 2024. PMID: 39425713. doi:10.1016/j.annemergmed.2024.08.508

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。